AhR activation in breast cancer stem cells increases proliferation via an elevation in sphingosine kinase 1 and S1P receptor activation[111], driven by AhR-mediated oxidation of S1P lyase at residue 317[112]. The gene discussed is AHR; the disease is breast carcinoma.